| Identification | Back Directory | [Name]
BOC-LEU-OME | [CAS]
63096-02-6 | [Synonyms]
BOC-LEU-OME
Boc-L-Leu-OMe
Boc-L-Leucine methyl
BOC-LEU-OME USP/EP/BP
BOC-L-LEUCYL METHYL ESTER
BOC-L-LEUCINE METHYL ESTER
(Tert-Butoxy)Carbonyl Leu-OMe
N-Boc-L-leucine Methyl ester, 97%
Boc-L-leucine methyl ester≥ 98% (HPLC)
Methyl (tert-butoxycarbonyl)-L-leucinate
Methyl N-(tert-butoxycarbonyl)-L-leucinate
N-(tert-Butoxycarbonyl)leucine methyl ester
N-(tert-Butyloxycarbonyl)leucine methyl ester
N-(TERT-BUTOXYCARBONYL)-L-LEUCINE METHYL ESTER
N-ALPHA-T-BUTOXYCARBONYL-L-LEUCINE-METHYL ESTER
N-(tert-Butyloxycarbonyl)-L-leucine methyl ester
N-(tert-Butoxycarbonyl)-L-leucine methyl ester 97%
3-[(2-acetamido-3-phenylpropanoyl)amino]benzoic acid
3-[(2-acetamido-3-phenyl-propanoyl)amino]benzoic acid
L-Leucine, N-[(1,1-diMethylethoxy)carbonyl]-, Methyl ester
(S)-Methyl 2-((tert-butoxycarbonyl)aMino)-4-Methylpentanoate
methyl (2S)-2-{[(tert-butoxy)carbonyl]amino}-4-methylpentanoate
(2S)-2-(tert-Butoxycarbonylamino)-4-methylpentanoic acid methyl ester
(2S)-2-(tert-Butyloxycarbonylamino)-4-methylpentanoic acid methyl ester
methyl(2S)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate | [Molecular Formula]
C12H23NO4 | [MDL Number]
MFCD00076952 | [MOL File]
63096-02-6.mol | [Molecular Weight]
245.32 |
| Chemical Properties | Back Directory | [Melting point ]
147-149℃ | [Boiling point ]
205 °C(lit.) | [density ]
0.991 g/mL at 25 °C(lit.) | [refractive index ]
n20/D 1.44(lit.) | [Fp ]
113 °C | [storage temp. ]
Store at 0°C | [form ]
Liquid | [color ]
Colorless to light yellow | [Optical Rotation]
[α]22/D 18°, neat |
| Hazard Information | Back Directory | [Chemical Properties]
Light yellowish liquid | [Uses]
Boc-L-leucine Methyl Ester is used in preparation of heterocyclic compound as hematopoietic prostaglandin D synthase (H-PGDS) inhibitor. | [reaction suitability]
reaction type: solution phase peptide synthesis | [Synthesis]
General procedure for the synthesis of (tert-butoxycarbonyl)-L-leucine methyl ester from di-tert-butyl dicarbonate and L-leucine methyl ester hydrochloride: firstly, L-leucine methyl ester hydrochloride and K2CO3 were suspended in water and stirred for 1 hour to release the free amino acid ester. Subsequently, the free amino acid ester was extracted with CH2Cl2 and the organic phase was dried with MgSO4. Evaporation of CH2Cl2 under reduced pressure gave the free amino acid ester, which should be used immediately in the next step of the N-Boc protection reaction. Next, the free amino acid ester (1 mmol) was dissolved in 1 mL of ethanol and added to a solution of di-tert-butyl dicarbonate (1.2 mmol) and guanidine hydrochloride (15 mol%) in ethanol (1 mL) that had been preheated to 35-40 °C and the reaction was stirred at the appropriate temperature. After completion of the reaction, the post-treatment procedure was the same as that for conventional amines. | [References]
[1] Tetrahedron Letters, 2011, vol. 52, # 12, p. 1260 - 1264
[2] Chemistry - A European Journal, 2013, vol. 19, # 12, p. 3817 - 3821
[3] Journal of Organic Chemistry, 1995, vol. 60, # 24, p. 8074 - 8080
[4] Chemical Biology and Drug Design, 2012, vol. 79, # 2, p. 216 - 222
[5] European Journal of Medicinal Chemistry, 2017, vol. 135, p. 142 - 158 |
|
|